Should People be Allowed To Sell Their Organs?
By Alice Park,
Time / CNN
| 07. 03. 2012
How much would it take for you to consider selling your bone marrow? A
U.S. appeals court puts the price at about $3,000 in a ruling that now
makes it legal to pay donors for their bone-marrow tissue.
The court's decision may
well help thousands of sick patients who need bone-marrow transplants to
survive, but it also begs the question, What other body parts might
next be up for sale?
The ruling
came about at the end of 2011, in a decision to an October 2009 lawsuit
brought by a group of cancer patients, parents and bone-marrow-donation
advocates against the government over the federal law banning the
buying and selling of bodily organs. The plaintiffs were led by Doreen
Flynn, who has three daughters who suffer from Fanconi anemia, a blood disorder that requires bone-marrow transplants to treat.
Flynn and the other
plaintiffs said that too many such patients die waiting for transplants
and argued that we should be allowed to pay people to donate their
marrow as a way of ensuring a more reliable supply. The U.S. Court...
Related Articles
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026
During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...